Prevalence of metabolic syndrome in children and adolescents with obesity: a systematic review and meta-analysis
- PMID: 39622709
- DOI: 10.1002/oby.24159
Prevalence of metabolic syndrome in children and adolescents with obesity: a systematic review and meta-analysis
Abstract
Objective: This study investigated the prevalence trends of metabolic syndrome (MetS) in children and adolescents with obesity by systematically analyzing global data. Additionally, it aimed to compare regional disparities and criteria used to identify at-risk subpopulations among this demographic group.
Methods: We searched three major databases, i.e., PubMed-Medline, Scopus, and Web of Science, from inception to August 31, 2023, yielding 2432 articles. We included original research papers reporting MetS prevalence among children and adolescents with obesity, irrespective of their regions and MetS diagnostic criteria used. We aggregated prevalence estimates using random-effects models to obtain the overall prevalence and conducted subgroup analyses for MetS criteria and study regions.
Results: We included 57 studies, amounting to 27,923 participants. The overall prevalence of MetS in participants with obesity varied greatly across studies, ranging from 2.1% to 74.4%, with an average prevalence of 29.4%. This high prevalence of MetS was further supported by a meta-analysis comprising 57 studies that further strengthened the observation of a high prevalence of MetS, revealing an overall prevalence of 26% (95% CI: 0.22-0.30; I2 = 98%).
Conclusions: Children and adolescents with obesity face a heightened risk of developing MetS. There is a pressing need for heightened attention to this issue, particularly in low- and middle-income countries such as those in sub-Saharan Africa.
© 2024 The Obesity Society.
Similar articles
-
Patient navigator programmes for children and adolescents with chronic diseases.Cochrane Database Syst Rev. 2024 Oct 9;10(10):CD014688. doi: 10.1002/14651858.CD014688.pub2. Cochrane Database Syst Rev. 2024. PMID: 39382077
-
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).Cochrane Database Syst Rev. 2015 Nov 25;2015(11):CD009885. doi: 10.1002/14651858.CD009885.pub2. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2023 Mar 27;3:CD009885. doi: 10.1002/14651858.CD009885.pub3. PMID: 26599576 Free PMC article. Updated.
-
Nutritional interventions for survivors of childhood cancer.Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD009678. doi: 10.1002/14651858.CD009678.pub2. Cochrane Database Syst Rev. 2016. PMID: 27545902 Free PMC article.
-
Incentives for preventing smoking in children and adolescents.Cochrane Database Syst Rev. 2017 Jun 6;6(6):CD008645. doi: 10.1002/14651858.CD008645.pub3. Cochrane Database Syst Rev. 2017. PMID: 28585288 Free PMC article.
-
E-Health interventions for anxiety and depression in children and adolescents with long-term physical conditions.Cochrane Database Syst Rev. 2018 Aug 15;8(8):CD012489. doi: 10.1002/14651858.CD012489.pub2. Cochrane Database Syst Rev. 2018. PMID: 30110718 Free PMC article.
Cited by
-
Developmental Trends of Metabolic Syndrome in the Past Two Decades: A Narrative Review.J Clin Med. 2025 Mar 31;14(7):2402. doi: 10.3390/jcm14072402. J Clin Med. 2025. PMID: 40217852 Free PMC article. Review.
-
The association between aggregate index of systemic inflammation and DXA-measured body composition parameters in adolescents.Front Physiol. 2025 Jun 9;16:1612735. doi: 10.3389/fphys.2025.1612735. eCollection 2025. Front Physiol. 2025. PMID: 40551896 Free PMC article.
-
Metabolic disorders in young people around the world.Diabetologia. 2025 Jun 17. doi: 10.1007/s00125-025-06450-2. Online ahead of print. Diabetologia. 2025. PMID: 40523943 Review.
-
Ferritin as an Inflammatory Marker in Pediatric Metabolic Syndrome: Links to Obesity and Liver Ultrasound Alterations.Int J Mol Sci. 2025 Apr 17;26(8):3793. doi: 10.3390/ijms26083793. Int J Mol Sci. 2025. PMID: 40332421 Free PMC article.
-
Cardiometabolic adverse effects of long-term antipsychotic treatment in children and adolescents with non-psychotic disorders: a systematic review of available evidence.Eur Child Adolesc Psychiatry. 2025 Jun 5. doi: 10.1007/s00787-025-02771-0. Online ahead of print. Eur Child Adolesc Psychiatry. 2025. PMID: 40471419 Review.
References
REFERENCES
-
- Wu S, Xu W, Guan C, Lv M, Jiang S, Jinhua Z. Global burden of cardiovascular disease attributable to metabolic risk factors, 1990‐2019: an analysis of observational data from a 2019 Global Burden of Disease study. BMJ Open. 2023;13(5):e069397.
-
- Lobstein T, Jackson‐Leach R, Powis J, Brindsden H, Gray M. World Obesity Atlas. World Obesity Federation; 2023.
-
- Chong B, Jayabaskaran J, Kong G, et al. Trends and predictions of malnutrition and obesity in 204 countries and territories: an analysis of the global burden of disease study 2019. Eclinicalmedicine. 2023;57:101850. doi:10.1016/j.eclinm.2023.101850
-
- Tremmel M, Gerdtham UG, Nilsson P, Saha S. Economic burden of obesity: a systematic literature review. Int J Environ Res Public Health. 2017;14(4):435.
-
- Scott A, Ejikeme CS, Clottey EN, Thomas JG. Obesity in sub‐Saharan Africa: development of an ecological theoretical framework. Health Promot Int. 2013;28(1):4‐16.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical